Exterran (EXTN) 10-Q 3 Nov 21 2021 Q3 Quarterly report Financial data

Cover Page

Cover Page - shares	9 Months Ended
	Sep. 30, 2021	Oct. 27, 2021
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2021
Document Transition Report	false
Entity File Number	001-36875
Entity Registrant Name	EXTERRAN CORPORATION
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	47-3282259
Entity Address, Address Line One	11000 Equity Drive
Entity Address, City or Town	Houston
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	77041
City Area Code	281
Local Phone Number	836-7000
Title of 12(b) Security	Common Stock, $0.01 par value per share
Trading Symbol	EXTN
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		33,303,552
Entity Central Index Key	0001635881
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q3

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 57,520	$ 40,318
Restricted cash	2,460	3,410
Accounts receivable, net of allowance of $10,307 and $10,803, respectively	179,594	198,028
Inventory (Note 4)	104,020	109,837
Contract assets (Note 2)	65,710	32,642
Other current assets	18,346	19,810
Current assets associated with discontinued operations (Note 3)	21,713	25,325
Total current assets	449,363	429,370
Property, plant and equipment, net (Note 5)	631,413	733,222
Long-term contract assets (Note 2)	18,169	33,563
Operating lease right-of-use assets	22,150	25,428
Deferred income taxes	7,949	8,866
Intangible and other assets, net	72,387	71,436
Long-term assets associated with discontinued operations (Note 3)	1,687	1,606
Total assets	1,203,118	1,303,491
Current liabilities:
Accounts payable, trade	60,303	60,078
Accrued liabilities	123,254	94,404
Contract liabilities (Note 2)	92,493	100,123
Current operating lease liabilities	5,454	6,340
Current liabilities associated with discontinued operations (Note 3)	3,422	13,707
Total current liabilities	284,926	274,652
Long-term debt (Note 6)	572,547	562,325
Deferred income taxes	2,275	1,014
Long-term contract liabilities (Note 2)	56,763	80,499
Long-term operating lease liabilities	26,966	29,868
Other long-term liabilities	43,454	57,159
Long-term liabilities associated with discontinued operations (Note 3)	1,007	2,142
Total liabilities	987,938	1,007,659
Commitments and contingencies (Note 14)
Stockholders’ equity:
Preferred stock, $0.01 par value per share; 50,000,000 shares authorized; zero issued	0	0
Common stock, $0.01 par value per share; 250,000,000 shares authorized; 38,041,255 and 37,804,206 shares issued, respectively	380	378
Additional paid-in capital	752,772	750,506
Accumulated deficit	(499,919)	(418,529)
Treasury stock - 4,737,703 and 4,665,560 common shares, at cost, respectively	(57,742)	(57,431)
Accumulated other comprehensive income	19,689	20,908
Total stockholders' equity	215,180	295,832
Total liabilities and stockholders’ equity	$ 1,203,118	$ 1,303,491

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Statement of Financial Position [Abstract]
Accounts receivable, allowance (US dollars)	$ 10,307	$ 10,803
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized	50,000,000	50,000,000
Preferred stock, shares issued	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized	250,000,000	250,000,000
Common stock, shares issued	38,041,255	37,804,206
Treasury stock, common shares	4,737,703	4,665,560

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Revenues (Note 2):
Revenue	$ 161,299	$ 169,511	$ 443,662	$ 461,362
Cost of sales (excluding depreciation and amortization expense):
Cost of sales (excluding depreciation and amortization expense)	93,924	101,946	241,148	268,671
Selling, general and administrative	34,938	29,959	101,199	95,049
Depreciation and amortization	43,889	36,630	132,097	100,887
Impairment	0	1,695	7,959	1,695
Restructuring and other charges (Note 9)	(62)	238	192	3,550
Interest expense	10,479	9,623	30,800	29,214
Gain on extinguishment of debt	0	(780)	0	(3,424)
Other (income) expense, net	(1,074)	1,178	(1,172)	(1,169)
Costs and expenses:	182,094	180,489	512,223	494,473
Loss before income taxes	(20,795)	(10,978)	(68,561)	(33,111)
Provision for (benefit from) for income taxes (Note 10)	(5,187)	5,745	11,105	18,970
Loss from continuing operations	(15,608)	(16,723)	(79,666)	(52,081)
Loss from discontinued operations, net of tax (Note 3)	(695)	(998)	(1,724)	(15,833)
Net loss	$ (16,303)	$ (17,721)	$ (81,390)	$ (67,914)
Basic net loss per common share
Loss from continuing operations per common share (in dollars per share)	$ (0.47)	$ (0.51)	$ (2.41)	$ (1.59)
Loss from discontinued operations per common share (in dollars per share)	(0.02)	(0.03)	(0.05)	(0.48)
Net loss per common share (in dollars per share)	(0.49)	(0.54)	(2.46)	(2.07)
Diluted net loss per common share
Income (Loss) from Continuing Operations, Per Diluted Share, Total	(0.47)	(0.51)	(2.41)	(1.59)
Loss from discontinued operations per common share (in dollars per share)	(0.02)	(0.03)	(0.05)	(0.48)
Net loss per common share (in dollars per share)	$ (0.49)	$ (0.54)	$ (2.46)	$ (2.07)
Weighted average common shares outstanding used in net loss per common share (Note 13):
Basic (in shares)	33,068,000	32,806,000	33,024,000	32,742,000
Diluted (in shares)	33,068,000	32,806,000	33,024,000	32,742,000
Contract operations
Revenues (Note 2):
Revenue	$ 83,362	$ 81,679	$ 251,874	$ 254,412
Cost of sales (excluding depreciation and amortization expense):
Cost of sales (excluding depreciation and amortization expense)	27,790	24,548	78,898	79,754
Aftermarket services
Revenues (Note 2):
Revenue	24,633	30,435	79,154	83,337
Cost of sales (excluding depreciation and amortization expense):
Cost of sales (excluding depreciation and amortization expense)	19,379	23,135	62,813	63,336
Product sales
Revenues (Note 2):
Revenue	53,304	57,397	112,634	123,613
Cost of sales (excluding depreciation and amortization expense):
Cost of sales (excluding depreciation and amortization expense)	$ 46,755	$ 54,263	$ 99,437	$ 125,581

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Statement of Comprehensive Income [Abstract]
Net loss	$ (16,303)	$ (17,721)	$ (81,390)	$ (67,914)
Other comprehensive loss:
Foreign currency translation adjustment	(2,021)	(2,080)	(1,219)	(16,866)
Comprehensive loss	$ (18,324)	$ (19,801)	$ (82,609)	$ (84,780)

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Treasury Stock	Accumulated Other Comprehensive Income
Beginning balance at Dec. 31, 2019	$ 409,538	$ 375	$ 747,622	$ (317,238)	$ (56,567)	$ 35,346
Increase (Decrease) in Stockholders' Equity
Net loss	(18,304)			(18,304)
Foreign currency translation adjustment	(11,056)					(11,056)
Treasury stock purchased	(835)				(835)
Stock-based compensation, net of forfeitures	285	2	283
Ending balance at Mar. 31, 2020	379,628	377	747,905	(335,542)	(57,402)	24,290
Beginning balance at Dec. 31, 2019	409,538	375	747,622	(317,238)	(56,567)	35,346
Increase (Decrease) in Stockholders' Equity
Net loss	(67,914)
Foreign currency translation adjustment	(16,866)
Ending balance at Sep. 30, 2020	325,976	378	749,694	(385,152)	(57,424)	18,480
Beginning balance at Mar. 31, 2020	379,628	377	747,905	(335,542)	(57,402)	24,290
Increase (Decrease) in Stockholders' Equity
Net loss	(31,889)			(31,889)
Foreign currency translation adjustment	(3,730)					(3,730)
Treasury stock purchased	(10)				(10)
Stock-based compensation, net of forfeitures	1,121	1	1,120
Ending balance at Jun. 30, 2020	345,120	378	749,025	(367,431)	(57,412)	20,560
Increase (Decrease) in Stockholders' Equity
Net loss	(17,721)			(17,721)
Foreign currency translation adjustment	(2,080)					(2,080)
Treasury stock purchased	(12)				(12)
Stock-based compensation, net of forfeitures	669		669
Ending balance at Sep. 30, 2020	325,976	378	749,694	(385,152)	(57,424)	18,480
Beginning balance at Dec. 31, 2020	295,832	378	750,506	(418,529)	(57,431)	20,908
Increase (Decrease) in Stockholders' Equity
Net loss	(29,873)			(29,873)
Foreign currency translation adjustment	(2,417)					(2,417)
Treasury stock purchased	(310)				(310)
Stock-based compensation, net of forfeitures	1,473	2	1,471
Ending balance at Mar. 31, 2021	264,705	380	751,977	(448,402)	(57,741)	18,491
Beginning balance at Dec. 31, 2020	295,832	378	750,506	(418,529)	(57,431)	20,908
Increase (Decrease) in Stockholders' Equity
Net loss	(81,390)
Foreign currency translation adjustment	(1,219)
Ending balance at Sep. 30, 2021	215,180	380	752,772	(499,919)	(57,742)	19,689
Beginning balance at Mar. 31, 2021	264,705	380	751,977	(448,402)	(57,741)	18,491
Increase (Decrease) in Stockholders' Equity
Net loss	(35,214)			(35,214)
Foreign currency translation adjustment	3,219					3,219
Stock-based compensation, net of forfeitures	431		431
Ending balance at Jun. 30, 2021	233,141	380	752,408	(483,616)	(57,741)	21,710
Increase (Decrease) in Stockholders' Equity
Net loss	(16,303)			(16,303)
Foreign currency translation adjustment	(2,021)					(2,021)
Treasury stock purchased	(1)				(1)
Stock-based compensation, net of forfeitures	364		364
Ending balance at Sep. 30, 2021	$ 215,180	$ 380	$ 752,772	$ (499,919)	$ (57,742)	$ 19,689

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Cash flows from operating activities:
Net loss	$ (81,390)	$ (67,914)
Adjustments to reconcile net loss to cash provided by operating activities:
Depreciation and amortization	132,097	100,887
Impairment	7,959	1,695
Amortization of deferred financing costs	1,991	1,871
Loss from discontinued operations, net of tax	1,724	15,833
Provision for doubtful accounts	825	4,449
Gain on sale of property, plant and equipment	(738)	(269)
(Gain) loss on remeasurement of intercompany balances	810	(3,822)
(Gain) loss on foreign currency derivatives	2,030	(27)
Gain on extinguishment of debt	0	(3,424)
Stock-based compensation expense	2,268	2,075
Deferred income tax expense	48	2,779
Changes in assets and liabilities:
Accounts receivable and notes	17,301	(10,777)
Inventory	5,682	3,695
Contract assets and contract liabilities, net	(60,969)	(18,230)
Other current assets	986	5,271
Accounts payable and other liabilities	7,230	(13,517)
Other	1,378	5,097
Net cash provided by continuing operations	39,232	25,672
Net cash used in discontinued operations	(9,614)	(19,884)
Net cash provided by operating activities	29,618	5,788
Cash flows from investing activities:
Capital expenditures	(23,585)	(65,852)
Proceeds from sale of property, plant and equipment	844	240
Net cash used in continuing operations	(22,741)	(65,612)
Net cash used in discontinued operations	0	(882)
Net cash used in investing activities	(22,741)	(66,494)
Cash flows from financing activities:
Proceeds from borrowings of debt	164,400	305,000
Repayments of debt	(154,292)	(229,560)
Purchases of treasury stock (Note 11)	(311)	(857)
Net cash provided by financing activities	9,797	74,583
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(422)	(750)
Net increase in cash, cash equivalents and restricted cash	16,252	13,127
Cash, cash equivalents and restricted cash at beginning of period	43,728	16,702
Cash, cash equivalents and restricted cash at end of period	59,980	29,829
Supplemental disclosure of non-cash transactions:
Accrued capital expenditures	$ 11,047	$ 2,529

Description of Business and Bas

Description of Business and Basis of Presentation	9 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
Description of Business and Basis of Presentation	Note 1 - Description of Business and Basis of Presentation Description of Business Exterran Corporation (together with its subsidiaries, “Exterran Corporation,” the “Company,” “our,” “we” or “us”), a Delaware corporation formed in March 2015, is a global sustainable systems and process company offering solutions in the oil, gas, water and power markets. We are a leader in natural gas processing and treatment, produced water treatment and compression products, solutions and services, providing critical midstream infrastructure solutions to customers throughout the world while helping them reduce their flaring, emissions and fresh water usage. We provide our products, solutions, and services to a global customer base consisting of companies engaged in all aspects of the oil and natural gas industry, including large integrated oil and natural gas companies, national oil and natural gas companies, independent oil and natural gas producers and oil and natural gas processors, gatherers and pipeline operators. Our manufacturing facilities are located in the United States of America (“U.S.”), Singapore and the United Arab Emirates. We operate in three primary business lines: contract operations, aftermarket services and product sales. In our contract operations business line, we provide processing, treating, compression and water treatment services through the operation of our natural gas and crude oil production and process equipment and natural gas compression equipment and water treatment equipment for our customers. In our aftermarket services business line, we sell parts and components and provide operations, maintenance, repair, overhaul, upgrade, startup and commissioning and reconfiguration services to customers who own their own oil and natural gas compression, production, processing, treating and related equipment. In our product sales business line, we design, engineer, manufacture, install and sell equipment used in the treating and processing of crude oil, natural gas, natural gas compression packages and water to our customers throughout the world and for use in our contract operations business line. We also offer our customers, on either a contract operations basis or a sale basis, the engineering, design, project management, procurement and construction services necessary to incorporate our products into production, processing and compression facilities, which we refer to as integrated projects. Basis of Presentation The accompanying unaudited condensed consolidated financial statements of Exterran Corporation included herein have been prepared in accordance with generally accepted accounting principles in the U.S. (“GAAP”) for interim financial information and the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP are not required in these interim financial statements and have been condensed or omitted. Management believes that the information furnished includes all adjustments of a normal recurring nature that are necessary to fairly state our consolidated financial position, results of operations and cash flows for the periods indicated. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements presented in our Annual Report on Form 10-K for the year ended December 31, 2020. That report contains a comprehensive summary of our accounting policies. The interim results reported herein are not necessarily indicative of results for a full year. We refer to the consolidated financial statements collectively as “financial statements,” and individually as “balance sheets,” “statements of operations,” “statements of comprehensive income (loss),” “statements of stockholders’ equity” and “statements of cash flows” herein. In March 2020, the World Health Organization declared the outbreak of the novel coronavirus (“COVID-19”) a pandemic. The COVID-19 pandemic has negatively impacted the global economy, disrupted global supply chains and created significant volatility and disruption across most industries. Efforts to mitigate the spread of COVID-19 have also resulted in decreased energy demand and additional weakness in energy pricing. To help control the spread of the virus and protect the health and safety of our employees and customers, we began temporarily closing our locations or modifying operating hours in our locations around the world. This was in response to governmental requirements including “stay-at-home” orders and similar mandates and in some of our locations, we voluntarily went beyond the requirements of local government authorities. The broader implications of COVID-19 on our long-term future results of operations and overall financial condition remains uncertain. Due to the rapid market deterioration during the three months ended March 31, 2020, we concluded that a trigger existed and that we should evaluate our long-term assets for impairment. Therefore, we updated our impairment analysis and concluded that no impairment existed during the three months ended March 31, 2020. No triggering events were identified subsequent to March 31, 2020, related to the ongoing COVID-19 pandemic. Recent Accounting Pronouncements We consider the applicability and impact of all Accounting Standard Updates (“ASUs”). ASUs not listed below were assessed and determined to be not applicable. Recently Adopted Accounting Pronouncements In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740) (“ASU 2019-12”): Simplifying the Accounting for Income Taxes. The update simplifies the accounting for income taxes and is effective for annual and interim periods beginning after December 15, 2020, with early adoption permitted. On January 1, 2021, we adopted this update. The adoption of this update was immaterial to our financial statements. In June 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848) (“ASU 2020-04”) . Topic 848 is effective for fiscal years and interim periods beginning as of March 12, 2020 through December 31, 2022. This update provides optional guidance for a limited period of time to ease the potential burden in accounting for reference rate reform on financial reporting. It is elective and applies to all entities, subject to meeting certain criteria, that have contracts, hedging relationships and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. The adoption of ASU 2020-04 did not have a material impact to our financial statements. Recently Issued Accounting Pronouncements Not Yet Adopted There are no recently issued accounting pronouncements not yet adopted that we are aware of at this time that would have a material impact on the Company.

Revenue

Revenue	9 Months Ended
	Sep. 30, 2021
Revenue from Contract with Customer [Abstract]
Revenue	Note 2 - Revenue Disaggregation of Revenue The following tables present disaggregated revenue by products and services lines and by geographical regions for the three and nine months ended September 30, 2021 and 2020 (in thousands): Three Months Ended September 30, Nine Months Ended September 30, Revenue by Products and Services 2021 2020 2021 2020 Contract Operations Segment: Contract operations services (1) $ 83,362 $ 81,679 $ 251,874 $ 254,412 Aftermarket Services Segment: Operation and maintenance services (1) $ 11,655 $ 12,966 $ 36,171 $ 38,184 Part sales (2) 10,680 11,490 33,000 31,999 Other services (1) 2,298 5,979 9,983 13,154 Total aftermarket services $ 24,633 $ 30,435 $ 79,154 $ 83,337 Product Sales Segment: Compression equipment (1) (3) $ 5,795 $ 40,300 $ 13,767 $ 73,654 Processing and treating equipment (1) 41,825 14,220 85,715 34,836 Other product sales (1) (2) 5,684 2,877 13,152 15,123 Total product sales revenues $ 53,304 $ 57,397 $ 112,634 $ 123,613 Total revenues $ 161,299 $ 169,511 $ 443,662 $ 461,362 (1) Revenue recognized over time. (2) Revenue recognized at a point in time. (3) Compression equipment includes sales to customers outside of the U.S. The compression fabrication business for sales to U.S. customers that was previously included in our product sales segment is now included in discontinued operations. Three Months Ended September 30, Nine Months Ended September 30, Revenue by Geographical Regions 2021 2020 2021 2020 North America $ 2,099 $ 13,364 $ 11,524 $ 31,694 Latin America 68,507 60,302 197,717 195,451 Middle East and Africa 81,034 69,682 200,192 177,768 Asia Pacific 9,659 26,163 34,229 56,449 Total revenues $ 161,299 $ 169,511 $ 443,662 $ 461,362 The North America region is primarily comprised of our operations in the U.S. The Latin America region is primarily comprised of our operations in Argentina, Bolivia, Brazil and Mexico. The Middle East and Africa region is primarily comprised of our operations in Bahrain, Iraq, Oman, Nigeria and the United Arab Emirates. The Asia Pacific region is primarily comprised of our operations in China, Indonesia, Singapore and Thailand. The following table summarizes the expected timing of revenue recognition from unsatisfied performance obligations (commonly referred to as backlog) as of September 30, 2021 (in thousands): Contract Operations Product Sales Segment Segment Remainder of 2021 $ 79,586 $ 76,553 2022 247,050 195,242 2023 251,867 59,787 2024 230,749 16,045 2025 209,521 17,557 Thereafter 414,537 — Total backlog $ 1,433,310 $ 365,184 Certain of our aftermarket services contracts are subject to cancellation or modification at the election of the customer. If the primary component of our contract operations contracts is the lease component, the contracts are accounted for as operating leases. For these contracts, revenues are recognized on a straight-line basis. As of September 30, 2021, the total value of our contracts operations backlog accounted for as operating leases was approximately $ 504.2 million , of which $ 10 million is expected to be recognized in the remainder of 2021, $ 44 million is expected to be recognized in 2022, $ 104 million is expected to be recognized in 2023, $ 94 million is expected to be recognized in 2024 and $ 79 million is expected to be recognized in 2025. Contract operations revenue recognized as operating leases for the nine months ended September 30, 2021 was approximately $ 27 million . Our product sales backlog includes contracts where there is a significant financing component. As of September 30, 2021, we had approximately $ 43 million expected to be recognized in future periods as interest income within our product sales segment. Contract Assets and Contract Liabilities The following table provides information about accounts receivables, net, contract assets and contract liabilities from contracts with customers (in thousands): September 30, 2021 December 31, 2020 Accounts receivables, net $ 179,594 $ 198,028 Contract assets and contract liabilities: Current contract assets 65,710 32,642 Long-term contract assets 18,169 33,563 Current contract liabilities 92,493 100,123 Long-term contract liabilities 56,763 80,499 During the nine months ended September 30, 2021, revenue recognized from contract operations services included $ 52.0 million of revenue deferred in previous periods. Revenue recognized during the nine months ended September 30, 2021 from product sales performance obligations partially satisfied in previous periods was $ 87.8 million , of which $ 27.7 million was included in billings in excess of costs at the beginning of the period. The increase in current contract assets during the nine months ended September 30, 2021 is primarily due to the timing of milestone billings in the Middle East and Africa region. The decrease in long-term contract assets during the nine months ended September 30, 2021 was primarily due to the timing of milestones billings in the Middle East and Africa region. The decrease in current contract liabilities during the nine months ended September 30, 2021 was primarily driven by the progression of product sales projects and the timing of milestones billings in the Middle East and Africa region. The decrease in long-term contract liabilities during the nine months ended September 30, 2021 was primarily driven by the acceleration of deferred revenue on two separate contracts due to a change in the terms in the Latin America region. Allowance for Doubtful Accounts The Company estimates its reserves using information about past events, current conditions and risk characteristics of each customer, and reasonable and supportable forecasts relevant to assessing risk associated with the collectability of accounts receivables, contract assets and long-term note receivables. The Company’s customer base has generally similar collectability risk characteristics, although larger customers may have lower risk than smaller independent customers. The allowance for doubtful accounts as of September 30, 2021 and changes for the nine months then ended are as follows (in thousands): Balance at December 31, 2020 $ 10,803 Write-offs during the period ( 496 ) Balance at September 30, 2021 $ 10,307

Discontinued Operations

Discontinued Operations	9 Months Ended
	Sep. 30, 2021
Discontinued Operations and Disposal Groups [Abstract]
Discontinued Operations	No te 3 - Discontinued Operations We have continued to work toward our strategy to be a company that leverages technology and operational excellence to provide complete systems and process solutions in energy and industrial applications. Over the past several years, we have made significant progress in this journey by taking actions to protect our core business, develop important organizational capabilities, commercialize new products, solutions, and services and implement new processes to position Exterran for success. We are focused on optimizing our portfolio of products and services to better serve our global customers while providing a more attractive investment option for our investors. As we continue on this path, we decided that our U.S. compression fabrication business was non-core to our strategy, and during the third quarter of 2020, we entered into an agreement to sell the assets used to operate the business which closed on November 2, 2020. We did not sell certain items in inventory, which we expect to liquidate over time. During the third quarter of 2020, this business met the held for sale criteria and is now reflected as discontinued operations in our financial statements for all periods presented. The U.S. compression fabrication business was previously included in our product sales segment and has been reclassified to discontinued operations in our financial statements for all periods presented. Compression revenue from sales to international customers continues to be included in our product sales segment. In addition, in connection with our review of options for the U.S. compression fabrication business, we reviewed the assets in this business compared to our estimate of future cash flows and recorded impairments of $ 6.5 million during the nine months ended September 30, 2020 to adjust the carrying value to our estimate of fair market value. In the first quarter of 2016, we began executing the exit of our Belleli EPC business that has historically been comprised of engineering, procurement and construction for the manufacture of tanks for tank farms and the manufacture of evaporators and brine heaters for desalination plants in the Middle East (referred to as “Belleli EPC” or the “Belleli EPC business” herein) by ceasing the bookings of new orders. As of the fourth quarter of 2017, we had substantially exited our Belleli EPC business and, in accordance with GAAP, it is reflected as discontinued operations in our financial statements for all periods presented. Although we have reached mechanical completion on all remaining Belleli EPC contracts, we are still subject to risks and uncertainties potentially resulting from warranty obligations, customer or supplier claims against us, settlement of claims against customers, completion of demobilization activities and litigation developments. The facility previously utilized to manufacture products for our Belleli EPC business has been repurposed to manufacture product sales equipment. As such, certain personnel, buildings, equipment and other assets that were previously related to our Belleli EPC business remain a part of our continuing operations. As a result, activities associated with our ongoing operations at our repurposed facility are included in continuing operations. The following table summarizes the operating results of discontinued operations (in thousands): Three Months Ended September 30, 2021 Three Months Ended September 30, 2020 Belleli EPC US Total Belleli EPC US Total Revenue $ — $ 2,944 $ 2,944 $ 1,100 $ 27,434 $ 28,534 Cost of sales (excluding depreciation and amortization — 3,324 3,324 84 25,371 25,455 Selling, general and administrative 234 — 234 ( 70 ) 1,387 1,317 Depreciation and amortization — — — — 443 443 Restructuring and other charges — 305 305 — 2,336 2,336 Other (income) expense, net 3 — 3 ( 52 ) — ( 52 ) Provision for (benefit from) income taxes ( 227 ) — ( 227 ) 33 — 33 Income (loss) from discontinued operations, net of tax $ ( 10 ) $ ( 685 ) $ ( 695 ) $ 1,105 $ ( 2,103 ) $ ( 998 ) Nine Months Ended September 30, 2021 Nine Months Ended September 30, 2020 Belleli EPC US Total Belleli EPC US Total Revenue $ — $ 2,997 $ 2,997 $ 1,224 $ 117,565 $ 118,789 Cost of sales (excluding depreciation and amortization 55 3,496 3,551 268 109,316 109,584 Selling, general and administrative 478 413 891 144 8,743 8,887 Depreciation and amortization — — — — 1,767 1,767 Impairments — — — — 6,512 6,512 Restructuring and other charges — 305 305 — 7,889 7,889 Other (income) expense, net 37 59 96 ( 3 ) — ( 3 ) Provision for (benefit from) income taxes ( 122 ) — ( 122 ) ( 14 ) — ( 14 ) Income (loss) from discontinued operations, net of tax $ ( 448 ) $ ( 1,276 ) $ ( 1,724 ) $ 829 $ ( 16,662 ) $ ( 15,833 ) The following table summarizes the balance sheet data for discontinued operations (in thousands): September 30, 2021 December 31, 2020 Belleli EPC US Total Belleli EPC US Total Accounts receivable $ 268 $ 3,065 $ 3,333 $ 268 $ 3,171 $ 3,439 Inventory — 17,964 17,964 — 21,107 21,107 Contract assets — 234 234 — 458 458 Other current assets 182 — 182 213 108 321 Total current assets associated with discontinued 450 21,263 21,713 481 24,844 25,325 Property, Plant, and Equipment — — — — — — Intangible and other assets, net 1,687 — 1,687 1,606 — 1,606 Total assets associated with discontinued operations $ 2,137 $ 21,263 $ 23,400 $ 2,087 $ 24,844 $ 26,931 Accounts payable $ 35 $ 173 $ 208 $ 139 $ 5,093 $ 5,232 Accrued liabilities 2,750 244 2,994 2,939 5,037 7,976 Contract liabilities 197 23 220 197 302 499 Total current liabilities associated with discontinued 2,982 440 3,422 3,275 10,432 13,707 Other long-term liabilities 722 285 1,007 765 1,377 2,142 Total liabilities associated with discontinued operations $ 3,704 $ 725 $ 4,429 $ 4,040 $ 11,809 $ 15,849

Inventory

Inventory	9 Months Ended
	Sep. 30, 2021
Inventory Disclosure [Abstract]
Inventory	Note 4 - Inventory Inventory consisted of the following amounts (in thousands): September 30, 2021 December 31, 2020 Parts and supplies $ 61,699 $ 65,576 Work in progress 39,150 41,020 Finished goods 3,171 3,241 Inventory $ 104,020 $ 109,837

Property, Plant and Equipment,

Property, Plant and Equipment, Net	9 Months Ended
	Sep. 30, 2021
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment, Net	Note 5 - Property, Plant and Equipment, Net Property, plant and equipment, net, consisted of the following (in thousands): September 30, 2021 December 31, 2020 Compression equipment, processing facilities and other fleet assets (1) $ 1,519,537 $ 1,562,528 Land and buildings 51,151 50,908 Transportation and shop equipment 54,065 54,763 Computer software 63,394 54,486 Other 40,372 40,305 1,728,519 1,762,990 Accumulated depreciation ( 1,097,106 ) ( 1,029,768 ) Property, plant and equipment, net $ 631,413 $ 733,222 (1) In the first quarter of 2021, we evaluated the salvage values of our property, plant and equipment. As a result of this evaluation, we changed the salvage values for our compression equipment to a maximum salvage value of 5 % from 15 % . During the three and nine months ended September 30, 2021, we recorded an increase to depreciation expense of approximately $ 1.0 million and $ 3.1 million , respectively as a result of this change in salvage value.

Debt

Debt	9 Months Ended
	Sep. 30, 2021
Debt Disclosure [Abstract]
Debt	Note 6 - Debt Debt consisted of the following (in thousands): September 30, 2021 December 31, 2020 Revolving credit facility due October 2023 $ 226,000 $ 216,500 8.125 % senior notes due May 2025 350,000 350,000 Other 608 — Unamortized deferred financing costs of 8.125 % senior notes ( 3,453 ) ( 4,175 ) Total debt 573,155 562,325 Less: Amounts within one year (1) ( 608 ) — Long-term debt $ 572,547 $ 562,325 (1) Short-term debt and the current portion of long-term debt are included in accrued liabilities in our balance sheets. Revolving Credit Facility Due October 2023 We and our wholly owned subsidiary, Exterran Energy Solutions, L.P. (“EESLP”), are parties to an amended and restated credit agreement (the “Amended Credit Agreement”) consisting of a $ 650.0 million revolving credit facility expiring in October 2023. As of September 30, 2021, we had $ 226.0 million in outstanding borrowings and $ 53.4 million in outstanding letters of credit under our revolving credit facility. At September 30, 2021, taking into account guarantees through letters of credit, we had undrawn capacity of $ 370.6 million under our revolving credit facility. Our Amended Credit Agreement limits our Total Debt to EBITDA ratio (as defined in the Amended Credit Agreement) on the last day of the fiscal quarter to no greater than 4.50 to 1.0. As a result of this limitation, $ 143.3 million of the $ 370.6 million of undrawn capacity under our revolving credit facility was available for additional borrowings as of September 30, 2021. The Amended Credit Agreement contains various covenants with which we, EESLP and our respective restricted subsidiaries must comply, including, but not limited to, limitations on the incurrence of indebtedness, investments, liens on assets, repurchasing equity, making distributions, transactions with affiliates, mergers, consolidations, dispositions of assets and other provisions customary in similar types of agreements. We are required to maintain, on a consolidated basis, a minimum interest coverage ratio (as defined in the Amended Credit Agreement) of 2.25 to 1.00; a maximum total leverage ratio (as defined in the Amended Credit Agreement) of 4.50 to 1.00; and a maximum senior secured leverage ratio (as defined in the Amended Credit Agreement) of 2.75 to 1.00. As of September 30, 2021, we maintained a 6.3 to 1.0 interest coverage ratio, a 3.6 to 1.0 total leverage ratio and a 1.4 to 1.0 senior secured leverage ratio. As of September 30, 2021, we were in compliance with all financial covenants under the Amended Credit Agreement. 8.125 % Senior Notes Due May 2025 In April 2017, our 100 % owned subsidiaries EESLP and EES Finance Corp. issued $ 375.0 million aggregate principal amount of 8.125 % senior unsecured notes due 2025 (the “2017 Notes”) which have $ 350.0 million outstanding as of September 30, 2021. We guarantee the 2017 Notes on a senior unsecured basis. We may redeem the 2017 Notes at any time in cash, in whole or part, at certain redemption prices, including the applicable make-whole premium plus accrued and unpaid interest, if any, to the date of redemption. During the nine months ended September 30, 2020 , we purchased and retired $ 24.0 million principal amount of our 2017 Notes for $ 20.6 million including $ 0.3 million of accrued interest. During the nine months ended September 30, 2020 , we recognized a gain on extinguishment of debt of $ 3.4 million, which was calculated as the difference between the repurchase price and the carrying amount of the 2017 Notes, partially offset by $ 0.2 million in related deferred financing costs.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Sep. 30, 2021
Fair Value Disclosures [Abstract]
Fair Value Measurements	Note 7 - Fair Value Measurements The accounting standard for fair value measurements and disclosures establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into the following three categories: • Level 1 — Quoted unadjusted prices for identical instruments in active markets to which we have access at the date of measurement. • Level 2 — Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets. Level 2 inputs are those in markets for which there are few transactions, the prices are not current, little public information exists or prices vary substantially over time or among brokered market makers. • Level 3 — Model derived valuations in which one or more significant inputs or significant value drivers are unobservable. Unobservable inputs are those inputs that reflect our own assumptions regarding how market participants would price the asset or liability based on the best available information. Recurring Fair Value Measurements The following table presents our assets and liabilities measured at fair value on a recurring basis as of September 30, 2021 and December 31, 2020, with pricing levels as of the date of valuation (in thousands): September 30, 2021 December 31, 2020 (Level 1) (Level 2) (Level 3) (Level 1) (Level 2) (Level 3) Foreign currency derivatives liabilities $ — $ — $ — $ — $ — $ ( 247 ) We are exposed to market risks associated with changes in foreign currency exchange rates, including foreign currency exchange rate changes recorded on intercompany obligations. From time to time, we may enter into foreign currency hedges to manage existing exposures to foreign exchange risk related to assets and liabilities recorded on our balance sheets including intercompany activity. During the nine months ended September 30, 2021, we recognized a loss of $ 2.0 million , on forward currency exchange contracts. As of September 30, 2021, we do not have derivative financial instruments outstanding to mitigate foreign currency risk. Nonrecurring Fair Value Measurements The following table presents our assets and liabilities measured at fair value on a nonrecurring basis during the nine months ended September 30, 2021 and 2020, with pricing levels as of the date of valuation (in thousands): Nine Months Ended September 30, 2021 Nine Months Ended September 30, 2020 (Level 1) (Level 2) (Level 3) (Level 1) (Level 2) (Level 3) Impaired long-lived assets (1) $ — $ — $ — $ — $ — $ — Long-term note receivable (2) — — 12,481 — — 11,165 (1) Our estimate of the fair value of the impaired long-lived assets as of September 30, 2021, were primarily based on the expectation that these assets are unlikely to generate future cash flows either through continuation of this contract or through proceeds from the sale of the assets and thus they were written down to zero. (2) Our estimate of the fair value of a note receivable was discounted based on a settlement period of eight years and a discount rate of 12.5 % . The undiscounted value of the note receivable, including interest, as of September 30, 2021 was $ 15.7 million . Financial Instruments Our financial instruments consist of cash, restricted cash, receivables, payables and debt. At September 30, 2021 and December 31, 2020, the estimated fair values of cash, restricted cash, receivables and payables approximated their carrying amounts as reflected in our balance sheets due to the short-term nature of these financial instruments. The fair value of the 2017 Notes was estimated based on model derived calculations using market yields observed in active markets, which are Level 2 inputs. As of September 30, 2021 and December 31, 2020, the carrying amount of the 2017 Notes, excluding unamortized deferred financing costs, of $ 350.0 million was estimated to have a fair value of $ 334.8 million and $ 297.0 million, respectively. Due to the variable rate nature of our revolving credit facility, the carrying value as of September 30, 2021 and December 31, 2020 approximated the fair value as the rate was comparable to the then-current market rate at which debt with similar terms could have been obtained.

Impairments

Impairments	9 Months Ended
	Sep. 30, 2021
Asset Impairment Charges [Abstract]
Impairments	Note 8 - Impairments We review long-lived assets, including property, plant and equipment and identifiable intangibles that are being amortized, for impairment whenever events or changes in circumstances, indicate that the carrying amount of an asset may not be recoverable. During the three months ended September 30, 2021, there were no events, or changes in circumstances to indicate that the carrying amount of an asset may not be recoverable. During the second quarter of the nine months ended September 30, 2021, we determined that there was no visibility to continuing a contract with a customer in the Latin America region. This contract included installation costs, deferred start-up costs and demobilization costs that were previously capitalized where it is highly unlikely we will generate future cash flows. As a result, during the nine months ended September 30, 2021, we recorded an $ 8.0 million asset impairment to reduce the book value of these assets to zero, which is its estimated fair value as of September 30, 2021.

Restructuring and Other Charges

Restructuring and Other Charges	9 Months Ended
	Sep. 30, 2021
Restructuring and Related Activities [Abstract]
Restructuring and Other Charges	Note 9 - Restructuring and Other Charges The energy industry’s focus on cash flow, capital discipline and improving returns has caused delays in the timing of new equipment orders. As a result, in the third quarter of 2019, we announced a cost reduction plan primarily focused on workforce reductions. During the three months ended September 30, 2021, we released an unused portion of previously expensed restructuring charges of $ 0.1 million and during the three months ended September 30, 2020, we incurred restructuring and other charges associated with these activities of $ 0.2 million . During the nine months ended September 30, 2021 and 2020, we incurred restructuring and other charges associated with these activities of $ 0.2 million and $ 3.6 million , respectively. These charges are reflected as restructuring and other charges in our statements of operations and accrued liabilities on our balance sheets. The cost reduction plan is expected to be completed in the fourth quarter of 2021 and we expect to settle these charges in cash. The following table summarizes the changes to our accrued liability balance related to restructuring and other charges for the nine months ended September 30, 2021 and 2020 (in thousands): Cost Reduction Plan Beginning balance at January 1, 2020 $ 2,281 Additions for costs expensed, net 3,550 Reductions for payments ( 3,791 ) Foreign exchange impact ( 393 ) Ending balance at September 30, 2020 $ 1,647 Beginning balance at January 1, 2021 $ 1,351 Additions for costs expensed, net 192 Reductions for payments ( 1,428 ) Foreign exchange impact 74 Ending balance at September 30, 2021 $ 189 The following table summarizes the components of charges included in restructuring and other charges in our statements of operations for the three and nine months ended September 30, 2021 and 2020 (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 2021 2020 Employee termination benefits $ ( 62 ) $ 238 $ 121 $ 986 Legal fees — — 71 2,564 Consulting fees — — — — Total restructuring and other charges $ ( 62 ) $ 238 $ 192 $ 3,550 The following table summarizes the components of charges included in restructuring and other charges incurred since the announcement of the cost reduction plan in the third quarter of 2019 (in thousands): Total Employee termination benefits $ 6,365 Legal fees 71 Consulting fees 3,205 Total restructuring and other charges $ 9,641

Provision for Income Taxes

Provision for Income Taxes	9 Months Ended
	Sep. 30, 2021
Income Tax Disclosure [Abstract]
Provision for Income Taxes	Note 10 - Provision for Income Taxes Our effective tax rate is affected by recurring items, such as tax rates in foreign jurisdictions and the relative amounts of income we earn, or losses we incur, in those jurisdictions. It is also affected by discrete items that may occur in any given year but are not consistent from year to year. Our effective tax rate is also affected by valuation allowances recorded against loss carryforwards in the U.S. and certain other jurisdictions, foreign withholding taxes and changes in foreign currency exchange rates. The following items had the most significant impact on the difference between our statutory U.S. federal income tax rate of 21 % and our effective tax rate of 24.9 % for the three months ended September 30, 2021: (i) a 16.2 % positive impact resulting from foreign currency devaluations in Argentina, (ii) a ( 4.3 )% negative impact resulting from foreign taxes in excess of the U.S. tax rate and other rate drivers, (iii) a 4.3 % positive impact resulting from deemed inclusions in the U.S. and (iv) a ( 9.8 )% negative impact resulting from an addition of valuation allowances against U.S. deferred tax assets. The following items had the most significant impact on the difference between our statutory U.S. federal income tax rate of 21 % and our effective tax rate of ( 16.2 )% for the nine months ended September 30, 2021: (i) a ( 3.1 )% negative impact resulting from foreign currency devaluations in Argentina, (ii) a ( 15.2 )% negative impact resulting from foreign taxes in excess of the U.S. tax rate and other rate drivers, (iii) a ( 7.1 )% negative impact resulting from deemed inclusions in the U.S. and (iv) a ( 7.5 )% negative impact resulting from an addition of valuation allowances against U.S. deferred tax assets. Our effective tax rate increased for the nine months ended September 30, 2021 compared to the nine months ended September 30, 2020 primarily due to an increase in valuation allowances recorded in the U.S., an increase in foreign taxes in excess of the U.S. tax rate, an increase in deemed inclusions in the U.S., a decrease in the FIN 48 reserve and a decrease in tax related to foreign exchange movement in Argentina.

Stockholders' Equity

Stockholders' Equity	9 Months Ended
	Sep. 30, 2021
Equity [Abstract]
Stockholders' Equity	Note 11 - Stockholders’ Equity Share Repurchase Program On February 20, 2019, our board of directors approved a share repurchase program under which the Company is authorized to purchase up to $ 100.0 million of its outstanding common stock through February 2022. The timing and method of any repurchases under the program will depend on a variety of factors, including prevailing market conditions among others. Purchases under the program may be suspended or discontinued at any time and we have no obligation to repurchase any amount of our common shares under the program. Shares of common stock acquired through the repurchase program are held in treasury at cost. During the nine months ended September 30, 2021 and 2020 , we did no t repurchase any shares under this program. As of September 30, 2021, the remaining authorized repurchase amount under the share repurchase program was $ 57.7 million . Additionally, treasury stock purchased during the nine months ended September 30, 2021 and 2020 included shares withheld to satisfy employees’ tax withholding obligations in connection with vesting of restricted stock awards.

Stock-Based Compensation

Stock-Based Compensation	9 Months Ended
	Sep. 30, 2021
Share-based Payment Arrangement [Abstract]
Stock-Based Compensation	Note 12 - Stock-Based Compensation Stock Options There were no stock options granted during the nine months ended September 30, 2021 and 2020. Restricted Stock, Restricted Stock Units and Performance Units For grants of restricted stock, restricted stock units and performance units, we recognize compensation expense over the applicable vesting period equal to the fair value of our common stock at the grant date. Grants of restricted stock, restricted stock units and performance units generally vest over two or three years proportionately on each grant date anniversary. The table below presents the changes in restricted stock, restricted stock units and performance units for our common stock during the nine months ended September 30, 2021. Equity Awards Liability Awards Weighted Average Weighted Average Shares Grant-Date Fair Shares Grant-Date Fair (in thousands) Value Per Share (in thousands) Value Per Share Non-vested awards, January 1, 2021 320 $ 16.02 1,198 $ 9.35 Granted 227 4.76 1,446 4.84 Vested ( 294 ) 12.85 ( 371 ) 14.02 Cancelled ( 11 ) 17.42 ( 55 ) 6.25 Non-vested awards, September 30, 2021 242 9.25 2,218 5.71 As of September 30, 2021, we estimate $ 6.6 million of unrecognized compensation cost related to unvested restricted stock, restricted stock units and performance units issued to our employees to be recognized over the weighted-average vesting period of 1.2 years.

Net Income (Loss) Per Common Sh

Net Income (Loss) Per Common Share	9 Months Ended
	Sep. 30, 2021
Earnings Per Share [Abstract]
Net Income (Loss) Per Common Share	Note 13 - Net Income (Loss) Per Common Share Basic net income (loss) per common share is computed using the two-class method, which is an earnings allocation formula that determines net income (loss) per share for each class of common stock and participating security according to dividends declared and participation rights in undistributed earnings. Under the two-class method, basic net income (loss) per common share is determined by dividing net income (loss) after deducting amounts allocated to participating securities, by the weighted average number of common shares outstanding for the period. Participating securities include unvested restricted stock and restricted stock units that have non-forfeitable rights to receive dividends or dividend equivalents, whether paid or unpaid. During periods of net loss from continuing operations, no effect is given to participating securities because they do not have a contractual obligation to participate in our losses. Diluted net income (loss) per common share is computed using the weighted average number of common shares outstanding adjusted for the incremental common stock equivalents attributed to outstanding options to purchase common stock and non-participating restricted stock units, unless their effect would be anti-dilutive. The following table presents a reconciliation of basic and diluted net loss per common share for the three and nine months ended September 30, 2021 and 2020 (in thousands, except per share data): Three Months Ended Nine Months Ended 2021 2020 2021 2020 Numerator for basic and diluted net loss per common share: Loss from continuing operations $ ( 15,608 ) $ ( 16,723 ) $ ( 79,666 ) $ ( 52,081 ) Loss from discontinued operations, net of tax ( 695 ) ( 998 ) ( 1,724 ) ( 15,833 ) Less: Net income attributable to participating securities — — — — Net loss — used in basic and diluted net loss per common share $ ( 16,303 ) $ ( 17,721 ) $ ( 81,390 ) $ ( 67,914 ) Weighted average common shares outstanding including participating 33,417 33,152 33,328 33,147 Less: Weighted average participating securities outstanding ( 349 ) ( 346 ) ( 304 ) ( 405 ) Weighted average common shares outstanding — used in basic net 33,068 32,806 33,024 32,742 Net dilutive potential common shares issuable: On exercise of options and vesting of restricted stock units * * * * Weighted average common shares outstanding — used in diluted net 33,068 32,806 33,024 32,742 Net loss per common share: Basic and diluted $ ( 0.49 ) $ ( 0.54 ) $ ( 2.46 ) $ ( 2.07 ) * Excluded from diluted net income (loss) per common share as their inclusion would have been anti-dilutive. The following table shows the potential shares of common stock issuable for the three and nine months ended September 30, 2021 and 2020 that were excluded from computing diluted net loss per common share as their inclusion would have been anti-dilutive (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 2021 2020 Net dilutive potential common shares issuable: On exercise of options where exercise price is greater than — 30 — 39 Net dilutive potential common shares issuable — 30 — 39

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	No te 14 - Commitments and Contingencies Contingencies We have agreements with financial institutions under which approximately $ 53.4 million of letters of credit or bank guarantees were outstanding as of September 30, 2021. These are put in place in certain situations to guarantee our performance obligations under contracts with counterparties. In addition to U.S. federal, state and local and foreign income taxes, we are subject to a number of taxes that are not income-based. As many of these taxes are subject to audit by the taxing authorities, it is possible that an audit could result in additional taxes due. We accrue for such additional taxes when we determine that it is probable that we have incurred a liability and we can reasonably estimate the amount of the liability. As of September 30, 2021 and December 31, 2020, we had accrued $ 1.5 million and $ 3.5 million, respectively, for the outcomes of non-income-based tax audits. We do not expect that the ultimate resolutions of these audits will result in a material variance from the amounts accrued. We do not accrue for unasserted claims for tax audits unless we believe the assertion of a claim is probable, it is probable that it will be determined that the claim is owed and we can reasonably estimate the claim or range of the claim. We do not have any unasserted claims from non-income based tax audits that we have determined are probable of assertion. We also believe the likelihood is remote that the impact of potential unasserted claims from non-income-based tax audits could be material to our financial position, but it is possible that the resolution of future audits could be material to our results of operations or cash flows for the period in which the resolution occurs. Our business can be hazardous, involving unforeseen circumstances such as uncontrollable flows of natural gas or well fluids and fires or explosions. As is customary in our industry, we review our safety equipment and procedures and carry insurance against some, but not all, risks of our business. Our insurance coverage includes property damage, general liability, commercial automobile liability and other coverage we believe is appropriate. We believe that our insurance coverage is customary for the industry and adequate for our business; however, losses and liabilities not covered by insurance would increase our costs. Additionally, we are substantially self-insured for workers’ compensation and employee group health claims in view of the relatively high per-incident deductibles we absorb under our insurance arrangements for these risks. Losses up to the deductible amounts are estimated and accrued based upon known facts, historical trends and industry averages. Litigation and Claims On December 19, 2020, we initiated arbitration in the International Court of Arbitration of the International Chamber of Commerce (“ICC”) against Iberoamericana de Hidrocarburos, S.A. De C.V. (“IHSA”) to collect approximately $ 38 million owed to us under three agreements, plus future lost profits, interest, attorneys’ fees, and other damages as allowed under the contracts and/or Mexican law. The three agreements relate to contract operation services provided to IHSA by Exterran. After we stopped providing services due to IHSA’s nonpayment, on December 29, 2020, IHSA filed a lawsuit in the 129th Judicial District Court of Harris County, Texas, for tortious interference with a contract and prospective business relationships, claiming damages for lost profits, lost production, loss of equipment, loss of business opportunity, damage to business reputation and attorneys’ fees. On March 2, 2021, after we moved IHSA’s lawsuit to the United States District Court for the Southern District of Texas, IHSA voluntarily dismissed the lawsuit. On May 11, 2021, IHSA again filed a similar claim in the 164th Judicial District Court of Harris County, Texas, for tortious interference with a contract and prospective business relationships, seeking damages in excess of $ 1 million. We moved IHSA’s lawsuit to the United States District Court for the Southern District of Texas, where it is currently pending. The court granted Exterran’s motion to compel arbitration and stayed the lawsuit. On April 27, 2021, IHSA answered Exterran’s request for arbitration before the ICC and included a counterclaim for approximately $ 27 million allegedly resulting from breach of contract, operational deficiencies, lost production, and lost profit. On September 13, 2021, IHSA served Exterran with a lawsuit filed with a court in Mexico seeking approximately $ 4.5 million for allegedly missing or damaged equipment. In addition, IHSA has orally threatened to draw certain bonds totaling approximately $ 12 million under one of the contracts for contract operation services. Based on currently available information we believe IHSA’s claims are without merit; however, IHSA’s claim are in the early stages and the results cannot be predicted with certainty. On July 5, 2021, Inesco Ingenieria & Construccion, S.A. (“Inesco”) filed a Demand for Arbitration in the ICC against Exterran Bolivia S.R.L. claiming it is owed approximately $ 13 million for certain goods and services allegedly provided to Exterran, delay damages, and increased expenses. Based on currently available information we believe Inesco’s claims are without merit; however, the results cannot be predicted with certainty. In the ordinary course of business, we are involved in various pending or threatened legal actions. While management is unable to predict the ultimate outcome of these actions, it believes that any ultimate liability arising from any of these actions will not have a material adverse effect on our financial position, results of operations or cash flows. However, because of the inherent uncertainty of litigation and arbitration proceedings, we cannot provide assurance that the resolution of any particular claim or proceeding to which we are a party will not have a material adverse effect on our financial position, results of operations or cash flows.

Reportable Segments

Reportable Segments	9 Months Ended
	Sep. 30, 2021
Segment Reporting [Abstract]
Reportable Segments	Note 15 - Reportable Segments Our chief operating decision maker manages business operations, evaluates performance and allocates resources based upon the type of product or service provided. We have three reportable segments: contract operations, aftermarket services and product sales. In our contract operations segment, we provide processing, treating, compression and water treatment services through the operation of our natural gas and crude oil production and process equipment, natural gas compression equipment and water treatment equipment for our customers. In our aftermarket services segment, we sell parts and components and provide operations, maintenance, repair, overhaul, upgrade, startup and commissioning and reconfiguration services to customers who own their own oil and natural gas compression, production, processing, treating and related equipment. In our product sales segment, we design, engineer, manufacture, install and sell equipment used in the treating and processing of crude oil, natural gas and water as well as natural gas compression packages to our customers throughout the world and for use in our contract operations business line. We evaluate the performance of our segments based on adjusted gross margin for each segment. Revenue only includes sales to external customers. We do not include intersegment sales when we evaluate our segments’ performance. The following table presents revenue and other financial information by reportable segment for the three and nine months ended September 30, 2021 and 2020 (in thousands): Reportable Contract Aftermarket Segments Three Months Ended September 30, Operations Services Product sales (2) Total 2021 Revenue $ 83,362 $ 24,633 $ 53,304 $ 161,299 Adjusted gross margin (1) 55,572 5,254 6,549 67,375 2020 Revenue $ 81,679 $ 30,435 $ 57,397 $ 169,511 Adjusted gross margin (1) 57,131 7,300 3,134 67,565 Reportable Contract Aftermarket Segments Nine Months Ended September 30, Operations Services Product sales (2) Total 2021 Revenue $ 251,874 $ 79,154 $ 112,634 $ 443,662 Adjusted gross margin(1) 172,976 16,341 13,197 202,514 2020 Revenue $ 254,412 $ 83,337 $ 123,613 $ 461,362 Adjusted gross margin(1) 174,658 20,001 ( 1,968 ) 192,691 (1) Adjusted gross margin is defined as revenue less cost of sales (excluding depreciation and amortization expense). (2) The U.S. compression fabrication business that was previously included in our product sales segment is now included in discontinued operations. The following table reconciles total gross margin to total adjusted gross margin (in thousands): Three Months Ended Nine Months Ended 2021 2020 2021 2020 Revenues $ 161,299 $ 169,511 $ 443,662 $ 461,362 Cost of sales (excluding depreciation and amortization 93,924 101,946 241,148 268,671 Depreciation and amortization (1) 42,008 35,182 126,861 96,489 Total gross margin 25,367 32,383 75,653 96,202 Depreciation and amortization (1) 42,008 35,182 126,861 96,489 Total adjusted gross margin $ 67,375 $ 67,565 $ 202,514 $ 192,691 (1) Represents the portion only attributable to cost of sales.

Description of Business and B_2

Description of Business and Basis of Presentation (Policies)	9 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements of Exterran Corporation included herein have been prepared in accordance with generally accepted accounting principles in the U.S. (“GAAP”) for interim financial information and the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP are not required in these interim financial statements and have been condensed or omitted. Management believes that the information furnished includes all adjustments of a normal recurring nature that are necessary to fairly state our consolidated financial position, results of operations and cash flows for the periods indicated. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements presented in our Annual Report on Form 10-K for the year ended December 31, 2020. That report contains a comprehensive summary of our accounting policies. The interim results reported herein are not necessarily indicative of results for a full year. We refer to the consolidated financial statements collectively as “financial statements,” and individually as “balance sheets,” “statements of operations,” “statements of comprehensive income (loss),” “statements of stockholders’ equity” and “statements of cash flows” herein. In March 2020, the World Health Organization declared the outbreak of the novel coronavirus (“COVID-19”) a pandemic. The COVID-19 pandemic has negatively impacted the global economy, disrupted global supply chains and created significant volatility and disruption across most industries. Efforts to mitigate the spread of COVID-19 have also resulted in decreased energy demand and additional weakness in energy pricing. To help control the spread of the virus and protect the health and safety of our employees and customers, we began temporarily closing our locations or modifying operating hours in our locations around the world. This was in response to governmental requirements including “stay-at-home” orders and similar mandates and in some of our locations, we voluntarily went beyond the requirements of local government authorities. The broader implications of COVID-19 on our long-term future results of operations and overall financial condition remains uncertain. Due to the rapid market deterioration during the three months ended March 31, 2020, we concluded that a trigger existed and that we should evaluate our long-term assets for impairment. Therefore, we updated our impairment analysis and concluded that no impairment existed during the three months ended March 31, 2020. No triggering events were identified subsequent to March 31, 2020, related to the ongoing COVID-19 pandemic.
Recent Accounting Pronouncements	Recent Accounting Pronouncements We consider the applicability and impact of all Accounting Standard Updates (“ASUs”). ASUs not listed below were assessed and determined to be not applicable. Recently Adopted Accounting Pronouncements In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740) (“ASU 2019-12”): Simplifying the Accounting for Income Taxes. The update simplifies the accounting for income taxes and is effective for annual and interim periods beginning after December 15, 2020, with early adoption permitted. On January 1, 2021, we adopted this update. The adoption of this update was immaterial to our financial statements. In June 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848) (“ASU 2020-04”) . Topic 848 is effective for fiscal years and interim periods beginning as of March 12, 2020 through December 31, 2022. This update provides optional guidance for a limited period of time to ease the potential burden in accounting for reference rate reform on financial reporting. It is elective and applies to all entities, subject to meeting certain criteria, that have contracts, hedging relationships and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. The adoption of ASU 2020-04 did not have a material impact to our financial statements. Recently Issued Accounting Pronouncements Not Yet Adopted There are no recently issued accounting pronouncements not yet adopted that we are aware of at this time that would have a material impact on the Company.

Revenue (Tables)

Revenue (Tables)	9 Months Ended
	Sep. 30, 2021
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	The following tables present disaggregated revenue by products and services lines and by geographical regions for the three and nine months ended September 30, 2021 and 2020 (in thousands): Three Months Ended September 30, Nine Months Ended September 30, Revenue by Products and Services 2021 2020 2021 2020 Contract Operations Segment: Contract operations services (1) $ 83,362 $ 81,679 $ 251,874 $ 254,412 Aftermarket Services Segment: Operation and maintenance services (1) $ 11,655 $ 12,966 $ 36,171 $ 38,184 Part sales (2) 10,680 11,490 33,000 31,999 Other services (1) 2,298 5,979 9,983 13,154 Total aftermarket services $ 24,633 $ 30,435 $ 79,154 $ 83,337 Product Sales Segment: Compression equipment (1) (3) $ 5,795 $ 40,300 $ 13,767 $ 73,654 Processing and treating equipment (1) 41,825 14,220 85,715 34,836 Other product sales (1) (2) 5,684 2,877 13,152 15,123 Total product sales revenues $ 53,304 $ 57,397 $ 112,634 $ 123,613 Total revenues $ 161,299 $ 169,511 $ 443,662 $ 461,362 (1) Revenue recognized over time. (2) Revenue recognized at a point in time. (3) Compression equipment includes sales to customers outside of the U.S. The compression fabrication business for sales to U.S. customers that was previously included in our product sales segment is now included in discontinued operations. Three Months Ended September 30, Nine Months Ended September 30, Revenue by Geographical Regions 2021 2020 2021 2020 North America $ 2,099 $ 13,364 $ 11,524 $ 31,694 Latin America 68,507 60,302 197,717 195,451 Middle East and Africa 81,034 69,682 200,192 177,768 Asia Pacific 9,659 26,163 34,229 56,449 Total revenues $ 161,299 $ 169,511 $ 443,662 $ 461,362
Schedule of Expected Timing of Revenue Recognition from Unsatisfied Performance Obligation	The following table summarizes the expected timing of revenue recognition from unsatisfied performance obligations (commonly referred to as backlog) as of September 30, 2021 (in thousands): Contract Operations Product Sales Segment Segment Remainder of 2021 $ 79,586 $ 76,553 2022 247,050 195,242 2023 251,867 59,787 2024 230,749 16,045 2025 209,521 17,557 Thereafter 414,537 — Total backlog $ 1,433,310 $ 365,184
Contract with Customer, Asset and Liability	The following table provides information about accounts receivables, net, contract assets and contract liabilities from contracts with customers (in thousands): September 30, 2021 December 31, 2020 Accounts receivables, net $ 179,594 $ 198,028 Contract assets and contract liabilities: Current contract assets 65,710 32,642 Long-term contract assets 18,169 33,563 Current contract liabilities 92,493 100,123 Long-term contract liabilities 56,763 80,499
Allowance for Doubtful Accounts	The allowance for doubtful accounts as of September 30, 2021 and changes for the nine months then ended are as follows (in thousands): Balance at December 31, 2020 $ 10,803 Write-offs during the period ( 496 ) Balance at September 30, 2021 $ 10,307

Discontinued Operations (Tables

Discontinued Operations (Tables)	9 Months Ended
	Sep. 30, 2021
Discontinued Operations and Disposal Groups [Abstract]
Summary of Operating Results and Balance Sheet Data for Discontinued Operations and Disposals	The following table summarizes the operating results of discontinued operations (in thousands): Three Months Ended September 30, 2021 Three Months Ended September 30, 2020 Belleli EPC US Total Belleli EPC US Total Revenue $ — $ 2,944 $ 2,944 $ 1,100 $ 27,434 $ 28,534 Cost of sales (excluding depreciation and amortization — 3,324 3,324 84 25,371 25,455 Selling, general and administrative 234 — 234 ( 70 ) 1,387 1,317 Depreciation and amortization — — — — 443 443 Restructuring and other charges — 305 305 — 2,336 2,336 Other (income) expense, net 3 — 3 ( 52 ) — ( 52 ) Provision for (benefit from) income taxes ( 227 ) — ( 227 ) 33 — 33 Income (loss) from discontinued operations, net of tax $ ( 10 ) $ ( 685 ) $ ( 695 ) $ 1,105 $ ( 2,103 ) $ ( 998 ) Nine Months Ended September 30, 2021 Nine Months Ended September 30, 2020 Belleli EPC US Total Belleli EPC US Total Revenue $ — $ 2,997 $ 2,997 $ 1,224 $ 117,565 $ 118,789 Cost of sales (excluding depreciation and amortization 55 3,496 3,551 268 109,316 109,584 Selling, general and administrative 478 413 891 144 8,743 8,887 Depreciation and amortization — — — — 1,767 1,767 Impairments — — — — 6,512 6,512 Restructuring and other charges — 305 305 — 7,889 7,889 Other (income) expense, net 37 59 96 ( 3 ) — ( 3 ) Provision for (benefit from) income taxes ( 122 ) — ( 122 ) ( 14 ) — ( 14 ) Income (loss) from discontinued operations, net of tax $ ( 448 ) $ ( 1,276 ) $ ( 1,724 ) $ 829 $ ( 16,662 ) $ ( 15,833 ) The following table summarizes the balance sheet data for discontinued operations (in thousands): September 30, 2021 December 31, 2020 Belleli EPC US Total Belleli EPC US Total Accounts receivable $ 268 $ 3,065 $ 3,333 $ 268 $ 3,171 $ 3,439 Inventory — 17,964 17,964 — 21,107 21,107 Contract assets — 234 234 — 458 458 Other current assets 182 — 182 213 108 321 Total current assets associated with discontinued 450 21,263 21,713 481 24,844 25,325 Property, Plant, and Equipment — — — — — — Intangible and other assets, net 1,687 — 1,687 1,606 — 1,606 Total assets associated with discontinued operations $ 2,137 $ 21,263 $ 23,400 $ 2,087 $ 24,844 $ 26,931 Accounts payable $ 35 $ 173 $ 208 $ 139 $ 5,093 $ 5,232 Accrued liabilities 2,750 244 2,994 2,939 5,037 7,976 Contract liabilities 197 23 220 197 302 499 Total current liabilities associated with discontinued 2,982 440 3,422 3,275 10,432 13,707 Other long-term liabilities 722 285 1,007 765 1,377 2,142 Total liabilities associated with discontinued operations $ 3,704 $ 725 $ 4,429 $ 4,040 $ 11,809 $ 15,849

Inventory (Tables)

Inventory (Tables)	9 Months Ended
	Sep. 30, 2021
Inventory Disclosure [Abstract]
Schedule of Inventory	Inventory consisted of the following amounts (in thousands): September 30, 2021 December 31, 2020 Parts and supplies $ 61,699 $ 65,576 Work in progress 39,150 41,020 Finished goods 3,171 3,241 Inventory $ 104,020 $ 109,837

Property, Plant and Equipment_2

Property, Plant and Equipment, Net (Tables)	9 Months Ended
	Sep. 30, 2021
Property, Plant and Equipment [Abstract]
Schedule of Property, Plant and Equipment, Net	Property, plant and equipment, net, consisted of the following (in thousands): September 30, 2021 December 31, 2020 Compression equipment, processing facilities and other fleet assets (1) $ 1,519,537 $ 1,562,528 Land and buildings 51,151 50,908 Transportation and shop equipment 54,065 54,763 Computer software 63,394 54,486 Other 40,372 40,305 1,728,519 1,762,990 Accumulated depreciation ( 1,097,106 ) ( 1,029,768 ) Property, plant and equipment, net $ 631,413 $ 733,222 (1) In the first quarter of 2021, we evaluated the salvage values of our property, plant and equipment. As a result of this evaluation, we changed the salvage values for our compression equipment to a maximum salvage value of 5 % from 15 % . During the three and nine months ended September 30, 2021, we recorded an increase to depreciation expense of approximately $ 1.0 million and $ 3.1 million , respectively as a result of this change in salvage value.

Debt (Tables)

Debt (Tables)	9 Months Ended
	Sep. 30, 2021
Debt Disclosure [Abstract]
Schedule of Debt	Debt consisted of the following (in thousands): September 30, 2021 December 31, 2020 Revolving credit facility due October 2023 $ 226,000 $ 216,500 8.125 % senior notes due May 2025 350,000 350,000 Other 608 — Unamortized deferred financing costs of 8.125 % senior notes ( 3,453 ) ( 4,175 ) Total debt 573,155 562,325 Less: Amounts within one year (1) ( 608 ) — Long-term debt $ 572,547 $ 562,325 (1) Short-term debt and the current portion of long-term debt are included in accrued liabilities in our balance sheets.

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2021
Fair Value Disclosures [Abstract]
Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis	The following table presents our assets and liabilities measured at fair value on a recurring basis as of September 30, 2021 and December 31, 2020, with pricing levels as of the date of valuation (in thousands): September 30, 2021 December 31, 2020 (Level 1) (Level 2) (Level 3) (Level 1) (Level 2) (Level 3) Foreign currency derivatives liabilities $ — $ — $ — $ — $ — $ ( 247 )
Schedule of Assets and Liabilities Measured at Fair Value on Nonrecurring Basis	The following table presents our assets and liabilities measured at fair value on a nonrecurring basis during the nine months ended September 30, 2021 and 2020, with pricing levels as of the date of valuation (in thousands): Nine Months Ended September 30, 2021 Nine Months Ended September 30, 2020 (Level 1) (Level 2) (Level 3) (Level 1) (Level 2) (Level 3) Impaired long-lived assets (1) $ — $ — $ — $ — $ — $ — Long-term note receivable (2) — — 12,481 — — 11,165 (1) Our estimate of the fair value of the impaired long-lived assets as of September 30, 2021, were primarily based on the expectation that these assets are unlikely to generate future cash flows either through continuation of this contract or through proceeds from the sale of the assets and thus they were written down to zero. (2) Our estimate of the fair value of a note receivable was discounted based on a settlement period of eight years and a discount rate of 12.5 % . The undiscounted value of the note receivable, including interest, as of September 30, 2021 was $ 15.7 million .

Restructuring and Other Charg_2

Restructuring and Other Charges (Tables)	9 Months Ended
	Sep. 30, 2021
Restructuring and Related Activities [Abstract]
Summary of Changes to Accrued Liability Balance Related to Restructuring and Other Charges	The following table summarizes the changes to our accrued liability balance related to restructuring and other charges for the nine months ended September 30, 2021 and 2020 (in thousands): Cost Reduction Plan Beginning balance at January 1, 2020 $ 2,281 Additions for costs expensed, net 3,550 Reductions for payments ( 3,791 ) Foreign exchange impact ( 393 ) Ending balance at September 30, 2020 $ 1,647 Beginning balance at January 1, 2021 $ 1,351 Additions for costs expensed, net 192 Reductions for payments ( 1,428 ) Foreign exchange impact 74 Ending balance at September 30, 2021 $ 189
Summary of the Components of Charges Included in Restructuring and Other Charges	The following table summarizes the components of charges included in restructuring and other charges in our statements of operations for the three and nine months ended September 30, 2021 and 2020 (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 2021 2020 Employee termination benefits $ ( 62 ) $ 238 $ 121 $ 986 Legal fees — — 71 2,564 Consulting fees — — — — Total restructuring and other charges $ ( 62 ) $ 238 $ 192 $ 3,550 The following table summarizes the components of charges included in restructuring and other charges incurred since the announcement of the cost reduction plan in the third quarter of 2019 (in thousands): Total Employee termination benefits $ 6,365 Legal fees 71 Consulting fees 3,205 Total restructuring and other charges $ 9,641

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	9 Months Ended
	Sep. 30, 2021
Share-based Payment Arrangement [Abstract]
Schedule of Changes in Restricted Stock, Restricted Stock Units, and Performance Units	The table below presents the changes in restricted stock, restricted stock units and performance units for our common stock during the nine months ended September 30, 2021. Equity Awards Liability Awards Weighted Average Weighted Average Shares Grant-Date Fair Shares Grant-Date Fair (in thousands) Value Per Share (in thousands) Value Per Share Non-vested awards, January 1, 2021 320 $ 16.02 1,198 $ 9.35 Granted 227 4.76 1,446 4.84 Vested ( 294 ) 12.85 ( 371 ) 14.02 Cancelled ( 11 ) 17.42 ( 55 ) 6.25 Non-vested awards, September 30, 2021 242 9.25 2,218 5.71
Schedule of Changes in Restricted Stock, Restricted Stock Units, and Performance Units	The table below presents the changes in restricted stock, restricted stock units and performance units for our common stock during the nine months ended September 30, 2021. Equity Awards Liability Awards Weighted Average Weighted Average Shares Grant-Date Fair Shares Grant-Date Fair (in thousands) Value Per Share (in thousands) Value Per Share Non-vested awards, January 1, 2021 320 $ 16.02 1,198 $ 9.35 Granted 227 4.76 1,446 4.84 Vested ( 294 ) 12.85 ( 371 ) 14.02 Cancelled ( 11 ) 17.42 ( 55 ) 6.25 Non-vested awards, September 30, 2021 242 9.25 2,218 5.71

Net Income (Loss) Per Common _2

Net Income (Loss) Per Common Share (Tables)	9 Months Ended
	Sep. 30, 2021
Earnings Per Share [Abstract]
Reconciliation of Basic and Diluted Net Loss Per Common Share	The following table presents a reconciliation of basic and diluted net loss per common share for the three and nine months ended September 30, 2021 and 2020 (in thousands, except per share data): Three Months Ended Nine Months Ended 2021 2020 2021 2020 Numerator for basic and diluted net loss per common share: Loss from continuing operations $ ( 15,608 ) $ ( 16,723 ) $ ( 79,666 ) $ ( 52,081 ) Loss from discontinued operations, net of tax ( 695 ) ( 998 ) ( 1,724 ) ( 15,833 ) Less: Net income attributable to participating securities — — — — Net loss — used in basic and diluted net loss per common share $ ( 16,303 ) $ ( 17,721 ) $ ( 81,390 ) $ ( 67,914 ) Weighted average common shares outstanding including participating 33,417 33,152 33,328 33,147 Less: Weighted average participating securities outstanding ( 349 ) ( 346 ) ( 304 ) ( 405 ) Weighted average common shares outstanding — used in basic net 33,068 32,806 33,024 32,742 Net dilutive potential common shares issuable: On exercise of options and vesting of restricted stock units * * * * Weighted average common shares outstanding — used in diluted net 33,068 32,806 33,024 32,742 Net loss per common share: Basic and diluted $ ( 0.49 ) $ ( 0.54 ) $ ( 2.46 ) $ ( 2.07 ) * Excluded from diluted net income (loss) per common share as their inclusion would have been anti-dilutive.
Schedule of Antidilutive Shares Excluded from Computation of Net Loss Per Common Share	The following table shows the potential shares of common stock issuable for the three and nine months ended September 30, 2021 and 2020 that were excluded from computing diluted net loss per common share as their inclusion would have been anti-dilutive (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 2021 2020 Net dilutive potential common shares issuable: On exercise of options where exercise price is greater than — 30 — 39 Net dilutive potential common shares issuable — 30 — 39

Reportable Segments (Tables)

Reportable Segments (Tables)	9 Months Ended
	Sep. 30, 2021
Segment Reporting [Abstract]
Schedule of Revenues and Other Financial Information	The following table presents revenue and other financial information by reportable segment for the three and nine months ended September 30, 2021 and 2020 (in thousands): Reportable Contract Aftermarket Segments Three Months Ended September 30, Operations Services Product sales (2) Total 2021 Revenue $ 83,362 $ 24,633 $ 53,304 $ 161,299 Adjusted gross margin (1) 55,572 5,254 6,549 67,375 2020 Revenue $ 81,679 $ 30,435 $ 57,397 $ 169,511 Adjusted gross margin (1) 57,131 7,300 3,134 67,565 Reportable Contract Aftermarket Segments Nine Months Ended September 30, Operations Services Product sales (2) Total 2021 Revenue $ 251,874 $ 79,154 $ 112,634 $ 443,662 Adjusted gross margin(1) 172,976 16,341 13,197 202,514 2020 Revenue $ 254,412 $ 83,337 $ 123,613 $ 461,362 Adjusted gross margin(1) 174,658 20,001 ( 1,968 ) 192,691 (1) Adjusted gross margin is defined as revenue less cost of sales (excluding depreciation and amortization expense). (2) The U.S. compression fabrication business that was previously included in our product sales segment is now included in discontinued operations.
Reconciliation of Total Gross Margin to Total Adjusted Gross Margin	The following table reconciles total gross margin to total adjusted gross margin (in thousands): Three Months Ended Nine Months Ended 2021 2020 2021 2020 Revenues $ 161,299 $ 169,511 $ 443,662 $ 461,362 Cost of sales (excluding depreciation and amortization 93,924 101,946 241,148 268,671 Depreciation and amortization (1) 42,008 35,182 126,861 96,489 Total gross margin 25,367 32,383 75,653 96,202 Depreciation and amortization (1) 42,008 35,182 126,861 96,489 Total adjusted gross margin $ 67,375 $ 67,565 $ 202,514 $ 192,691 (1) Represents the portion only attributable to cost of sales.

Description of Business and B_3

Description of Business and Basis of Presentation - Narrative (Details)	9 Months Ended
	Sep. 30, 2021BusinessLine
Accounting Policies [Abstract]
Number of business lines	3

Revenue - Disaggregation by Pro

Revenue - Disaggregation by Products and Services (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Disaggregation of Revenue [Line Items]
Revenue	$ 161,299	$ 169,511	$ 443,662	$ 461,362
Contract operations
Disaggregation of Revenue [Line Items]
Revenue	83,362	81,679	251,874	254,412
Contract operations | Revenue recognized over time
Disaggregation of Revenue [Line Items]
Revenue	83,362	81,679	251,874	254,412
Aftermarket services
Disaggregation of Revenue [Line Items]
Revenue	24,633	30,435	79,154	83,337
Aftermarket services | Operation and maintenance services | Revenue recognized over time
Disaggregation of Revenue [Line Items]
Revenue	11,655	12,966	36,171	38,184
Aftermarket services | Part sales | Revenue recognized at a point in time
Disaggregation of Revenue [Line Items]
Revenue	10,680	11,490	33,000	31,999
Aftermarket services | Other services | Revenue recognized over time
Disaggregation of Revenue [Line Items]
Revenue	2,298	5,979	9,983	13,154
Product sales
Disaggregation of Revenue [Line Items]
Revenue	53,304	57,397	112,634	123,613
Product sales | Compression equipment | Revenue recognized over time
Disaggregation of Revenue [Line Items]
Revenue	5,795	40,300	13,767	73,654
Product sales | Processing and treating equipment | Revenue recognized over time
Disaggregation of Revenue [Line Items]
Revenue	41,825	14,220	85,715	34,836
Product sales | Other product sales | Transferred over time and transferred at point in time
Disaggregation of Revenue [Line Items]
Revenue	$ 5,684	$ 2,877	$ 13,152	$ 15,123

Revenue - Disaggregation by Geo

Revenue - Disaggregation by Geographical Regions (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Disaggregation of Revenue [Line Items]
Revenue	$ 161,299	$ 169,511	$ 443,662	$ 461,362
North America
Disaggregation of Revenue [Line Items]
Revenue	2,099	13,364	11,524	31,694
Latin America
Disaggregation of Revenue [Line Items]
Revenue	68,507	60,302	197,717	195,451
Middle East and Africa
Disaggregation of Revenue [Line Items]
Revenue	81,034	69,682	200,192	177,768
Asia Pacific
Disaggregation of Revenue [Line Items]
Revenue	$ 9,659	$ 26,163	$ 34,229	$ 56,449

Revenue - Performance Obligatio

Revenue - Performance Obligations (Details) $ in Thousands	Sep. 30, 2021USD ($)
Contract operations
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Expected timing of revenue recognition from unsatisfied performance obligations	$ 1,433,310
Contract operations | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-10-01
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Expected timing of satisfaction, period	3 months
Expected timing of revenue recognition from unsatisfied performance obligations	$ 79,586
Contract operations | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-01-01
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Expected timing of satisfaction, period	1 year
Expected timing of revenue recognition from unsatisfied performance obligations	$ 247,050
Contract operations | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Expected timing of satisfaction, period	1 year
Expected timing of revenue recognition from unsatisfied performance obligations	$ 251,867
Contract operations | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Expected timing of satisfaction, period	1 year
Expected timing of revenue recognition from unsatisfied performance obligations	$ 230,749
Contract operations | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Expected timing of satisfaction, period	1 year
Expected timing of revenue recognition from unsatisfied performance obligations	$ 209,521
Contract operations | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Expected timing of satisfaction, period
Expected timing of revenue recognition from unsatisfied performance obligations	$ 414,537
Product sales
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Expected timing of revenue recognition from unsatisfied performance obligations	$ 365,184
Product sales | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-10-01
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Expected timing of satisfaction, period	3 months
Expected timing of revenue recognition from unsatisfied performance obligations	$ 76,553
Product sales | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-01-01
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Expected timing of satisfaction, period	1 year
Expected timing of revenue recognition from unsatisfied performance obligations	$ 195,242
Product sales | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Expected timing of satisfaction, period	1 year
Expected timing of revenue recognition from unsatisfied performance obligations	$ 59,787
Product sales | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Expected timing of satisfaction, period	1 year
Expected timing of revenue recognition from unsatisfied performance obligations	$ 16,045
Product sales | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Expected timing of satisfaction, period	1 year
Expected timing of revenue recognition from unsatisfied performance obligations	$ 17,557
Product sales | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Expected timing of satisfaction, period
Expected timing of revenue recognition from unsatisfied performance obligations	$ 0

Revenue - Performance Obligat_2

Revenue - Performance Obligations (Details1) $ in Thousands	Sep. 30, 2021USD ($)
Contract operations
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Expected timing of revenue recognition from unsatisfied performance obligations	$ 1,433,310
Product sales
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Expected timing of revenue recognition from unsatisfied performance obligations	$ 365,184

Revenue - Expected Timing of Re

Revenue - Expected Timing of Revenue Recognition (Details)	Sep. 30, 2021USD ($)
Operating lease contracts
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Expected timing of revenue recognition from unsatisfied performance obligations	$ 504,200
Product sales
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Expected timing of revenue recognition from unsatisfied performance obligations	365,184,000
Financing | Product sales
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Expected timing of revenue recognition from unsatisfied performance obligations	43,000
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-10-01 | Operating lease contracts
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Expected timing of revenue recognition from unsatisfied performance obligations	$ 10,000,000
Expected timing of satisfaction, period	3 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-10-01 | Product sales
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Expected timing of revenue recognition from unsatisfied performance obligations	$ 76,553,000
Expected timing of satisfaction, period	3 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-01-01 | Operating lease contracts
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Expected timing of revenue recognition from unsatisfied performance obligations	$ 44,000,000
Expected timing of satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-01-01 | Product sales
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Expected timing of revenue recognition from unsatisfied performance obligations	$ 195,242,000
Expected timing of satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01 | Operating lease contracts
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Expected timing of revenue recognition from unsatisfied performance obligations	$ 104,000,000
Expected timing of satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01 | Product sales
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Expected timing of revenue recognition from unsatisfied performance obligations	$ 59,787,000
Expected timing of satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01 | Operating lease contracts
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Expected timing of revenue recognition from unsatisfied performance obligations	$ 94,000,000
Expected timing of satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01 | Product sales
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Expected timing of revenue recognition from unsatisfied performance obligations	$ 16,045,000
Expected timing of satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01 | Operating lease contracts
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Expected timing of revenue recognition from unsatisfied performance obligations	$ 79,000,000
Expected timing of satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01 | Product sales
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Expected timing of revenue recognition from unsatisfied performance obligations	$ 17,557,000
Expected timing of satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01 | Product sales
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Expected timing of revenue recognition from unsatisfied performance obligations	$ 0
Expected timing of satisfaction, period

Revenue - Expected Timing of _2

Revenue - Expected Timing of Revenue Recognition (Details1)	Sep. 30, 2021USD ($)
Operating lease contracts
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Expected timing of revenue recognition from unsatisfied performance obligations	$ 504,200
Product sales
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Expected timing of revenue recognition from unsatisfied performance obligations	365,184,000
Financing | Product sales
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Expected timing of revenue recognition from unsatisfied performance obligations	$ 43,000

Revenue (Additional Information

Revenue (Additional Information) (Details) $ in Millions	9 Months Ended
	Sep. 30, 2021USD ($)
Disaggregation of Revenue [Line Items]
Operating lease income	$ 27
Revenue recognized from contract operations services including revenue deferred in previous periods	52
Product sales
Disaggregation of Revenue [Line Items]
Performance obligation satisfied in previous periods	87.8
Performance obligation satisfied in previous periods, included in billings in excess of costs	$ 27.7

Revenue - Contract Assets and C

Revenue - Contract Assets and Contract Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Revenue from Contract with Customer [Abstract]
Accounts receivables, net	$ 179,594	$ 198,028
Contract assets and contract liabilities:
Current contract assets	65,710	32,642
Long-term contract assets	18,169	33,563
Current contract liabilities	92,493	100,123
Long-term contract liabilities	$ 56,763	$ 80,499

Revenue - Allowance for Doubtfu

Revenue - Allowance for Doubtful Accounts (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2021USD ($)
Accounts Receivable, Allowance for Credit Loss [Roll Forward]
Beginning balance	$ 10,803
Write-offs during the period	(496)
Ending balance	$ 10,307

Discontinued Operations - Summa

Discontinued Operations - Summary of Operating Results (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Impairments	$ 0	$ 1,695	$ 7,959	$ 1,695
Income (loss) from discontinued operations, net of tax	(695)	(998)	(1,724)	(15,833)
Discontinued Operations
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Revenue	2,944	28,534	2,997	118,789
Cost of sales (excluding depreciation and amortization expense)	3,324	25,455	3,551	109,584
Selling, general and administrative	234	1,317	891	8,887
Depreciation and amortization	0	443	0	1,767
Impairments			0	6,512
Restructuring and other charges	305	2,336	305	7,889
Other (income) expense, net	3	(52)	96	(3)
Provision for (benefit from) income taxes	(227)	33	(122)	(14)
Income (loss) from discontinued operations, net of tax	(695)	(998)	(1,724)	(15,833)
Belleli EPC | Exit of Business
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Revenue	0	1,100	0	1,224
Cost of sales (excluding depreciation and amortization expense)	0	84	55	268
Selling, general and administrative	234	(70)	478	144
Depreciation and amortization	0	0	0	0
Impairments			0	0
Restructuring and other charges	0	0	0	0
Other (income) expense, net	3	(52)	37	(3)
Provision for (benefit from) income taxes	(227)	33	(122)	(14)
Income (loss) from discontinued operations, net of tax	(10)	1,105	(448)	829
US Compression | Disposed of by Sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Revenue	2,944	27,434	2,997	117,565
Cost of sales (excluding depreciation and amortization expense)	3,324	25,371	3,496	109,316
Selling, general and administrative	0	1,387	413	8,743
Depreciation and amortization	0	443	0	1,767
Impairments			0	6,512
Restructuring and other charges	305	2,336	305	7,889
Other (income) expense, net	0	0	59	0
Provision for (benefit from) income taxes	0	0	0	0
Income (loss) from discontinued operations, net of tax	$ (685)	$ (2,103)	$ (1,276)	$ (16,662)

Discontinued Operations - Sum_2

Discontinued Operations - Summary of Balance Sheet Data (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Current contract assets	$ 65,710	$ 32,642
Total current assets associated with discontinued operations	21,713	25,325
Total current liabilities associated with discontinued operations	3,422	13,707
Discontinued Operations
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Accounts receivable	3,333	3,439
Inventory	17,964	21,107
Current contract assets	234	458
Other current assets	182	321
Total current assets associated with discontinued operations	21,713	25,325
Property, Plant, and Equipment	0	0
Intangible and other assets, net	1,687	1,606
Total assets associated with discontinued operations	23,400	26,931
Accounts payable	208	5,232
Accrued liabilities	2,994	7,976
Contract liabilities	220	499
Total current liabilities associated with discontinued operations	3,422	13,707
Other long-term liabilities	1,007	2,142
Total liabilities associated with discontinued operations	4,429	15,849
Belleli EPC | Exit of Business
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Accounts receivable	268	268
Inventory	0	0
Current contract assets	0	0
Other current assets	182	213
Total current assets associated with discontinued operations	450	481
Property, Plant, and Equipment	0	0
Intangible and other assets, net	1,687	1,606
Total assets associated with discontinued operations	2,137	2,087
Accounts payable	35	139
Accrued liabilities	2,750	2,939
Contract liabilities	197	197
Total current liabilities associated with discontinued operations	2,982	3,275
Other long-term liabilities	722	765
Total liabilities associated with discontinued operations	3,704	4,040
US Compression | Disposed of by Sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Accounts receivable	3,065	3,171
Inventory	17,964	21,107
Current contract assets	234	458
Other current assets	0	108
Total current assets associated with discontinued operations	21,263	24,844
Property, Plant, and Equipment	0	0
Intangible and other assets, net	0	0
Total assets associated with discontinued operations	21,263	24,844
Accounts payable	173	5,093
Accrued liabilities	244	5,037
Contract liabilities	23	302
Total current liabilities associated with discontinued operations	440	10,432
Other long-term liabilities	285	1,377
Total liabilities associated with discontinued operations	$ 725	$ 11,809

Inventory (Details)

Inventory (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Composition of Inventory net of reserves
Parts and supplies	$ 61,699	$ 65,576
Work in progress	39,150	41,020
Finished goods	3,171	3,241
Inventory	$ 104,020	$ 109,837

Property, Plant and Equipment_3

Property, Plant and Equipment, Net (Details) - USD ($) $ in Thousands		3 Months Ended	9 Months Ended
		Sep. 30, 2021	Sep. 30, 2021	Mar. 31, 2021	Dec. 31, 2020
Property, Plant and Equipment
Property, plant and equipment, gross		$ 1,728,519	$ 1,728,519		$ 1,762,990
Accumulated depreciation		(1,097,106)	(1,097,106)		(1,029,768)
Property, plant and equipment, net		631,413	631,413		733,222
Compression equipment, processing facilities and other fleet assets
Property, Plant and Equipment
Property, plant and equipment, gross	[1]	1,519,537	1,519,537		$ 1,562,528
Compression equipment, processing facilities and other fleet assets | Salvage Value
Property, Plant and Equipment
Salvage value (in percent)				5.00%	15.00%
Depreciation expense		1,000	3,100
Land and buildings
Property, Plant and Equipment
Property, plant and equipment, gross		51,151	51,151		$ 50,908
Transportation and shop equipment
Property, Plant and Equipment
Property, plant and equipment, gross		54,065	54,065		54,763
Computer software
Property, Plant and Equipment
Property, plant and equipment, gross		63,394	63,394		54,486
Other
Property, Plant and Equipment
Property, plant and equipment, gross		$ 40,372	$ 40,372		$ 40,305
[1]	In the first quarter of 2021, we evaluated the salvage values of our property, plant and equipment. As a result of this evaluation, we changed the salvage values for our compression equipment to a maximum salvage value of 5 % from 15 % . During the three and nine months ended September 30, 2021, we recorded an increase to depreciation expense of approximately $ 1.0 million and $ 3.1 million , respectively as a result of this change in salvage value.

Debt - Schedule of Debt (Detail

Debt - Schedule of Debt (Details) - USD ($) $ in Thousands		Sep. 30, 2021	Dec. 31, 2020
Debt Instrument [Line Items]
Other		$ 608	$ 0
Total debt		573,155	562,325
Less: Amounts due within one year	[1]	(608)	0
Long-term debt (Note 6)		572,547	562,325
8.125% senior notes due May 2025 | Senior Notes
Debt Instrument [Line Items]
Long-term Debt		350,000	350,000
Unamortized deferred financing costs of 8.125% senior notes		$ (3,453)	(4,175)
Stated interest rate		8.125%
Revolving credit facility due October 2023
Debt Instrument [Line Items]
Long-term Debt		$ 226,000	$ 216,500
[1]	Short-term debt and the current portion of long-term debt are included in accrued liabilities in our balance sheets.

Debt - Revolving Credit Facilit

Debt - Revolving Credit Facility (Narrative) (Details) $ in Millions	Sep. 30, 2021USD ($)
Debt Instrument [Line Items]
Outstanding letters of credit	$ 53.4
Revolving credit facility
Debt Instrument [Line Items]
Maximum senior secured leverage ratio	2.75
Maximum total leverage ratio	4.50
Maximum interest coverage ratio	2.25
Revolving credit facility | Amended Credit Agreement
Debt Instrument [Line Items]
Borrowing capacity under restated credit agreement	$ 650
Senior secured leverage ratio	1.4
Total leverage ratio	3.6
Interest coverage ratio	6.3
Revolving credit facility | Credit Agreement
Debt Instrument [Line Items]
Outstanding borrowings	$ 226
Outstanding letters of credit	53.4
Undrawn capacity under revolving credit facility	$ 370.6
Total debt to EBITDA ratio	4.50
Undrawn capacity available	$ 143.3

Debt - 8.125% Senior Notes Due

Debt - 8.125% Senior Notes Due May 2025 (Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020	Apr. 30, 2017
Debt Instrument [Line Items]
Repayments of debt			$ 154,292	$ 229,560
Gain on extinguishment of debt	$ 0	$ 780	0	3,424
Revolving credit facility due October 2023
Debt Instrument [Line Items]
Long-term Debt	$ 226,000		$ 226,000		$ 216,500
Subsidiaries | EESLP And EES Finance Corp. | Exterran Corporation
Debt Instrument [Line Items]
Ownership percentage by parent						100.00%
8.125% senior notes due May 2025 | Senior unsecured notes
Debt Instrument [Line Items]
Stated interest rate	8.125%		8.125%
Long-term Debt	$ 350,000		$ 350,000		$ 350,000
Amount of debt extinguished				24,000
Repayments of debt				20,600
Payments for accrued interest				200
Gain on extinguishment of debt				3,400
Write off of deferred financing cost				$ 300
8.125% senior notes due May 2025 | Subsidiaries | Senior unsecured notes | EESLP And EES Finance Corp.
Debt Instrument [Line Items]
Stated interest rate						8.125%
Aggregate principal amount of senior unsecured notes						$ 375,000

Fair Value Measurements - Recur

Fair Value Measurements - Recurring Measurements (Details) - Fair Value, Recurring - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
(Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign currency derivatives liabilities	$ 0	$ 0
(Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign currency derivatives liabilities	0	0
(Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign currency derivatives liabilities	$ 0	$ (247)

Fair Value Measurements - Narra

Fair Value Measurements - Narrative (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Foreign Exchange Contract
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loss recognized on forward currency exchange contracts	$ 2
Senior Notes | 8.125% senior notes due May 2025 | Reported Value Measurement
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of notes	350	$ 350
Senior Notes | 8.125% senior notes due May 2025 | Estimate of Fair Value Measurement
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of notes	$ 334.8	$ 297

Fair Value Measurements - Nonre

Fair Value Measurements - Nonrecurring Measurements (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2021USD ($)	Sep. 30, 2020USD ($)
Summary of assets and liabilities measured at fair value on nonrecurring basis
Undiscounted value of note receivable Including Interest	$ 15,700
Nonrecurring | Maturiy
Summary of assets and liabilities measured at fair value on nonrecurring basis
Settlement period	8 years
Nonrecurring | Discount rate
Summary of assets and liabilities measured at fair value on nonrecurring basis
Discount rate	0.125
Nonrecurring | (Level 1)
Summary of assets and liabilities measured at fair value on nonrecurring basis
Impaired long-lived assets	$ 0	$ 0
Long-term note receivable	0	0
Nonrecurring | (Level 2)
Summary of assets and liabilities measured at fair value on nonrecurring basis
Impaired long-lived assets	0	0
Long-term note receivable	0	0
Nonrecurring | (Level 3)
Summary of assets and liabilities measured at fair value on nonrecurring basis
Impaired long-lived assets	0	0
Long-term note receivable	$ 12,481	$ 11,165

Impairments (Details)

Impairments (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Asset Impairment Charges [Abstract]
Impairments	$ 0	$ 1,695	$ 7,959	$ 1,695

Restructuring and Other Charg_3

Restructuring and Other Charges - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges	$ (62)	$ 238	$ 192	$ 3,550
Cost Reduction Plan
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges	$ 100	$ 200	$ 200	$ 3,600

Restructuring and Other Charg_4

Restructuring and Other Charges - Summary of Charges to Accrued Liability Balance (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Restructuring Reserve [Roll Forward]
Restructuring and other charges	$ (62)	$ 238	$ 192	$ 3,550
Restructuring and other charges incurred to date	9,641		9,641
Employee termination benefits
Restructuring Reserve [Roll Forward]
Restructuring and other charges	(62)	238	121	986
Restructuring and other charges incurred to date	6,365		6,365
Consulting fees
Restructuring Reserve [Roll Forward]
Restructuring and other charges	0	0	0	0
Restructuring and other charges incurred to date	3,205		3,205
Legal Fees
Restructuring Reserve [Roll Forward]
Restructuring and other charges	0	0	71	2,564
Restructuring and other charges incurred to date	71		71
Cost Reduction Plan
Restructuring Reserve [Roll Forward]
Beginning balance			1,351	2,281
Additions for costs expensed, net			192	3,550
Reductions for payments			(1,428)	(3,791)
Foreign exchange impact			74	(393)
Ending balance	189	1,647	189	1,647
Restructuring and other charges	$ 100	$ 200	$ 200	$ 3,600

Provision for Income Taxes (Det

Provision for Income Taxes (Details)	3 Months Ended	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2021
Income Tax Disclosure [Abstract]
Federal income tax rate	21.00%	21.00%
Effective tax rate	24.90%	(16.20%)
Foreign currency devaluation	16.20%	(3.10%)
Foreign withholding tax rate differential	(4.30%)	(15.20%)
Deemed inclusion in the US	4.30%	(7.10%)
Deferred tax assets valuation	(9.80%)	(7.50%)

Stockholders' Equity (Details)

Stockholders' Equity (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Feb. 20, 2019
Equity [Abstract]
Share repurchase program, authorized purchase amount			$ 100
Shares repurchased (in shares)	0	0
Remaining authorized share repurchase amount	$ 57.7

Stock-Based Compensation - Narr

Stock-Based Compensation - Narrative (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options granted (in shares)	0	0
Restricted stock, restricted stock units and performance units for common stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Estimated unrecognized compensation cost	$ 6.6
Weighted-average vesting period	1 year 2 months 12 days
Minimum | Restricted stock, restricted stock units and performance units for common stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	2 years
Maximum | Restricted stock, restricted stock units and performance units for common stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	3 years

Stock-Based Compensation - Sche

Stock-Based Compensation - Schedule of Restricted Stock, Restricted Stock Units and Performance Units for Common Stock (Details) shares in Thousands	9 Months Ended
	Sep. 30, 2021$ / sharesshares
Equity Awards
Shares
Non-vested awards at the beginning of the period | shares	320
Granted | shares	227
Vested | shares	(294)
Cancelled | shares	(11)
Non-vested awards at the end of the period | shares	242
Weighted Average Grant-Date Fair  Value Per Share
Non-vested awards at the beginning of the period (in dollars per share) | $ / shares	$ 16.02
Granted (in dollars per share) | $ / shares	4.76
Vested (in dollars per share) | $ / shares	12.85
Cancelled (in dollars per share) | $ / shares	17.42
Non-vested awards at the end of the period (in dollars per share) | $ / shares	$ 9.25
Liability Awards
Shares
Non-vested awards at the beginning of the period | shares	1,198
Granted | shares	1,446
Vested | shares	(371)
Cancelled | shares	(55)
Non-vested awards at the end of the period | shares	2,218
Weighted Average Grant-Date Fair  Value Per Share
Non-vested awards at the beginning of the period (in dollars per share) | $ / shares	$ 9.35
Granted (in dollars per share) | $ / shares	4.84
Vested (in dollars per share) | $ / shares	14.02
Cancelled (in dollars per share) | $ / shares	6.25
Non-vested awards at the end of the period (in dollars per share) | $ / shares	$ 5.71

Net Income (Loss) Per Common _3

Net Income (Loss) Per Common Share - Reconciliation of Basic and Diluted Net Income (Loss) Per Common Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Numerator for basic and diluted net loss per common share:
Loss from continuing operations	$ (15,608)	$ (16,723)	$ (79,666)	$ (52,081)
Loss from discontinued operations, net of tax	(695)	(998)	(1,724)	(15,833)
Less: Net income attributable to participating securities	0	0	0	0
Net loss — used in basic and diluted net loss per common share	$ (16,303)	$ (17,721)	$ (81,390)	$ (67,914)
Weighted average common shares outstanding including participating securities
Weighted average common shares outstanding including participating securities (in shares)	33,417,000	33,152,000	33,328,000	33,147,000
Less: Weighted average participating securities outstanding (in shares)	(349,000)	(346,000)	(304,000)	(405,000)
Weighted average common shares outstanding — used in basic net loss per common share (in shares)	33,068,000	32,806,000	33,024,000	32,742,000
Net dilutive potential common shares issuable:
Weighted average common shares outstanding — used in diluted net loss per common share (in shares)	33,068,000	32,806,000	33,024,000	32,742,000
Net loss per common share:
Basic (in dollars per share)	$ (0.49)	$ (0.54)	$ (2.46)	$ (2.07)
Diluted (in dollars per share)	$ (0.49)	$ (0.54)	$ (2.46)	$ (2.07)

Net Income (Loss) Per Common _4

Net Income (Loss) Per Common Share - Schedule of Antidilutive Shares (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Net dilutive potential common shares issuable (in shares)	0	30	0	39
On exercise of options where exercise price is greater than average market value
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Net dilutive potential common shares issuable (in shares)	0	30	0	39

Commitments and Contingencies -

Commitments and Contingencies - Contingencies (Details) - USD ($) $ in Millions	Sep. 30, 2021	Dec. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Outstanding letters of credit	$ 53.4
Amount accrued for the outcomes of non-income-based tax audits	$ 1.5	$ 3.5

Commitments and Contingencies_2

Commitments and Contingencies - Litigation (Details) - USD ($) $ in Millions	Sep. 13, 2021	Jul. 05, 2021	May 11, 2021	Dec. 19, 2020	Apr. 27, 2021
Loss Contingencies [Line Items]
Amount of Legal Claim		$ 13	$ 1	$ 38
Mexico
Loss Contingencies [Line Items]
Damages Sought Value	$ 4.5
Pending litigation
Loss Contingencies [Line Items]
Estimate of possible loss					$ 27
Threatened litigation
Loss Contingencies [Line Items]
Estimate of possible loss					$ 12

Reportable Segments - Narrative

Reportable Segments - Narrative (Details)	9 Months Ended
	Sep. 30, 2021Segment
Segment Reporting [Abstract]
Number of reportable segments	3

Reportable Segments - Schedule

Reportable Segments - Schedule of Revenues and Other Financial Information (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Segment Reporting Information [Line Items]
Revenue		$ 161,299	$ 169,511	$ 443,662	$ 461,362
Total adjusted gross margin		67,375	67,565	202,514	192,691
Operating Segments
Segment Reporting Information [Line Items]
Revenue		161,299	169,511	443,662	461,362
Total adjusted gross margin	[1]	67,375	67,565	202,514	192,691
Contract operations
Segment Reporting Information [Line Items]
Revenue		83,362	81,679	251,874	254,412
Contract operations | Operating Segments
Segment Reporting Information [Line Items]
Revenue		83,362	81,679	251,874	254,412
Total adjusted gross margin	[1]	55,572	57,131	172,976	174,658
Aftermarket Services
Segment Reporting Information [Line Items]
Revenue		24,633	30,435	79,154	83,337
Aftermarket Services | Operating Segments
Segment Reporting Information [Line Items]
Revenue		24,633	30,435	79,154	83,337
Total adjusted gross margin	[1]	5,254	7,300	16,341	20,001
Product sales
Segment Reporting Information [Line Items]
Revenue		53,304	57,397	112,634	123,613
Product sales | Operating Segments
Segment Reporting Information [Line Items]
Revenue	[2]	53,304	57,397	112,634	123,613
Total adjusted gross margin	[1],[2]	$ 6,549	$ 3,134	$ 13,197	$ (1,968)
[1]	Adjusted gross margin is defined as revenue less cost of sales (excluding depreciation and amortization expense).
[2]	The U.S. compression fabrication business that was previously included in our product sales segment is now included in discontinued operations.

Reportable Segments - Reconcili

Reportable Segments - Reconciliation of Total Gross Margin to Total Adjusted Gross Margin (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Segment Reporting [Abstract]
Revenue		$ 161,299	$ 169,511	$ 443,662	$ 461,362
Cost of sales (excluding depreciation and amortization expense)		93,924	101,946	241,148	268,671
Depreciation and amortization	[1]	42,008	35,182	126,861	96,489
Total gross margin		25,367	32,383	75,653	96,202
Total adjusted gross margin		$ 67,375	$ 67,565	$ 202,514	$ 192,691
[1]	Represents the portion only attributable to cost of sales.